Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0480
+0.00338 (7.58%)
At close: Apr 14, 2026
Hepion Pharmaceuticals Employees
Hepion Pharmaceuticals had 2 employees as of December 31, 2025. The number of employees decreased by 20 or -90.91% compared to the previous year.
Employees
2
Change
-20
Growth
-90.91%
Revenue / Employee
n/a
Profits / Employee
-$4,138,925
Market Cap
518.50K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | -20 | -90.91% |
| Dec 31, 2023 | 22 | -3 | -12.00% |
| Dec 31, 2022 | 25 | 5 | 25.00% |
| Dec 31, 2021 | 20 | 7 | 53.85% |
| Dec 31, 2020 | 13 | 1 | 8.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Scorpius Holdings | 91 |
| Emmaus Life Sciences | 33 |
| Eloxx Pharmaceuticals | 10 |
| Iterum Therapeutics | 9 |
| Innovation Pharmaceuticals | 4 |
| Bio-Path Holdings | 1 |
| Actavia Life Sciences | 1 |
Hepion Pharmaceuticals News
- 6 weeks ago - Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma - GlobeNewsWire
- 10 months ago - Hepion Pharmaceuticals Successfully Completes Application to the OTCQB - GlobeNewsWire
- 1 year ago - Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq - GlobeNewsWire
- 1 year ago - Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC - GlobeNewsWire
- 1 year ago - Hepion Pharmaceuticals Announces Reverse Stock Split - GlobeNewsWire
- 1 year ago - Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd. - GlobeNewsWire
- 1 year ago - Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson's Disease Study Group - GlobeNewsWire
- 1 year ago - Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B - GlobeNewsWire